Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/56520| Title: | Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer |
| Authors: | Micallef, Darren Micallef, Sarah Schembri-Wismayer, Pierre Calleja-Agius, Jean |
| Keywords: | Chemoprevention Breast neoplasms Hydroxymethylglutaryl-CoA Reductase Inhibitors Metformin Breast -- Cancer |
| Issue Date: | 2016 |
| Publisher: | AVES İbrahim KARA |
| Citation: | Micallef, D., Micallef, S., Schembri-Wismayer, P., & Calleja-Agius, J. (2016). Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer. Journal of the Turkish German Gynecological Association, 17(4), 214. |
| Abstract: | Recent evidence shows that commonly prescribed drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), metformin, and statins, may have beneficial roles in the primary chemoprevention of breast cancer. Therefore, these drugs could potentially be used in addition to the hormonal drugs currently used for this purpose (namely, selective estrogen receptor modulators and aromatase inhibitors) due to their alternative mechanisms of action. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/56520 |
| Appears in Collections: | Scholarly Works - FacM&SAna |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Novel_applications_of_COX_2_inhibitors_metformin_and_statins_for_the_primary_chemoprevention_of_breast_cancer.pdf | 200.71 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.